Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bispecific prodrug nanoparticles circumventing multiple immune resistance mechanisms for promoting cancer immunotherapy
Jiayi Ye, Bo Hou, Fangmin Chen, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 6, pp. 2695-2709
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Emerging Strategies in Stimuli-Responsive Prodrug Nanosystems for Cancer Therapy
Chendi Ding, Chunbo Chen, Xiaowei Zeng, et al.
ACS Nano (2022) Vol. 16, Iss. 9, pp. 13513-13553
Open Access | Times Cited: 99
Acid‐Ionizable Iron Nanoadjuvant Augments STING Activation for Personalized Vaccination Immunotherapy of Cancer
Fangmin Chen, Tianliang Li, Huijuan Zhang, et al.
Advanced Materials (2022) Vol. 35, Iss. 10
Closed Access | Times Cited: 75
Smart and versatile biomaterials for cutaneous wound healing
Minxiong Li, Wenzheng Xia, Yi Min Khoong, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 43
Bispecific antibodies in cancer therapy: Target selection and regulatory requirements
Yanze Sun, Xinmiao Yu, Xiao Wang, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 9, pp. 3583-3597
Open Access | Times Cited: 42
Leveraging Semiconducting Polymer Nanoparticles for Combination Cancer Immunotherapy
Jiayan Wu, Kanyi Pu
Advanced Materials (2023) Vol. 36, Iss. 1
Closed Access | Times Cited: 42
Nanoplatform-enhanced photodynamic therapy for the induction of immunogenic cell death
Xu Liu, Yichao Lu, Xiang Li, et al.
Journal of Controlled Release (2024) Vol. 365, pp. 1058-1073
Closed Access | Times Cited: 27
Mitochondrial Disruption Nanosystem Simultaneously Depressed Programmed Death Ligand-1 and Transforming Growth Factor-β to Overcome Photodynamic Immunotherapy Resistance
Xin Jiang, Yi Lei, Cheng Li, et al.
ACS Nano (2024) Vol. 18, Iss. 4, pp. 3331-3348
Closed Access | Times Cited: 17
Near-infrared photoactivatable semiconducting polymer nanocomplexes with bispecific metabolism interventions for enhanced cancer immunotherapy
Ningyue Yu, Mengbin Ding, Fengshuo Wang, et al.
Nano Today (2022) Vol. 46, pp. 101600-101600
Closed Access | Times Cited: 48
Amplifying “eat me signal” by immunogenic cell death for potentiating cancer immunotherapy
Yong Xi, Lijie Chen, Jian Tang, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 94-114
Closed Access | Times Cited: 41
Nanovesicles loaded with a TGF-β receptor 1 inhibitor overcome immune resistance to potentiate cancer immunotherapy
Mengxue Zhou, Jiaxin Wang, Jiaxing Pan, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 39
Emerging Epigenetic‐Based Nanotechnology for Cancer Therapy: Modulating the Tumor Microenvironment
Jiaxin Zhang, Leaf Huang, Guangbo Ge, et al.
Advanced Science (2023) Vol. 10, Iss. 7
Open Access | Times Cited: 27
Recent progress, perspectives, and issues of engineered PD-L1 regulation nano-system to better cure tumor: A review
Zaigang Zhou, Haoxiang Wang, Jie Li, et al.
International Journal of Biological Macromolecules (2023) Vol. 254, pp. 127911-127911
Closed Access | Times Cited: 27
Dendritic nanomedicine enhances chemo-immunotherapy by disturbing metabolism of cancer-associated fibroblasts for deep penetration and activating function of immune cells
Yunkun Li, Xiaoding Shen, Ding Haitao, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 8, pp. 3680-3696
Open Access | Times Cited: 10
A region-confined PROTAC nanoplatform for spatiotemporally tunable protein degradation and enhanced cancer therapy
Jing Gao, Xingyu Jiang, Shumin Lei, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Unprecedented Chiral Nanovaccines for Significantly Enhanced Cancer Immunotherapy
Hongxin Liu, Zhigang Xie, Min Zheng
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 35, pp. 39858-39865
Closed Access | Times Cited: 30
Targeting Warburg effect to rescue the suffocated photodynamic therapy: A cancer-specific solution
Yaoquan Su, Keqiang Lu, Yuhang Huang, et al.
Biomaterials (2023) Vol. 294, pp. 122017-122017
Closed Access | Times Cited: 21
Targeted Radium Alpha Therapy in the Era of Nanomedicine: In Vivo Results
György Trencsényi, Csaba Csikos, Zita Képes
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 664-664
Open Access | Times Cited: 6
Multi-functional nanomedicines for combinational cancer immunotherapy that transform cold tumors to hot tumors
Hanhee Cho, Kwangmeyung Kim
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 4, pp. 627-638
Closed Access | Times Cited: 6
Engineering Bioinspired Nanomedicines to Mitigate the Resistance to Cancer Immunotherapy
Jiayi Ye, Bo Hou, Madiha Saeed, et al.
Accounts of Materials Research (2022) Vol. 3, Iss. 7, pp. 697-708
Closed Access | Times Cited: 21
Dual-targeting prodrug nanotheranostics for NIR-Ⅱ fluorescence imaging-guided photo-immunotherapy of glioblastoma
Fenglin Li, Yi Lai, Jiayi Ye, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 9, pp. 3486-3497
Open Access | Times Cited: 19
Self‐Adaptive Nanoregulator to Mitigate Dynamic Immune Evasion of Pancreatic Cancer
Jiaxing Pan, Yi Lai, Shunan Zhang, et al.
Advanced Materials (2023) Vol. 35, Iss. 47
Closed Access | Times Cited: 12
Advances and prospects of RNA delivery nanoplatforms for cancer therapy
Mohamed S. Attia, Gregor Kijanka, Nam‐Trung Nguyen, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 15, Iss. 1, pp. 52-96
Open Access | Times Cited: 4
Fine-tuning the activation behaviors of ternary modular cabazitaxel prodrugs for efficient and on-target oral anti-cancer therapy
Mingyang Zhang, Yifan Miao, Can Zhao, et al.
Asian Journal of Pharmaceutical Sciences (2024) Vol. 19, Iss. 2, pp. 100908-100908
Open Access | Times Cited: 3
Therapeutic regulation of epigenetics in cancer treatment through drug delivery systems
Boyu Su, Shangkuo Li, Shuo Geng, et al.
Nano Today (2024) Vol. 56, pp. 102251-102251
Closed Access | Times Cited: 3
Sequentially Activatable Polypeptide Nanoparticles for Combinatory Photodynamic Chemotherapy of Breast Cancer
Huijuan Zhang, Jiaxing Pan, Tingting Wang, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 35, pp. 39787-39798
Closed Access | Times Cited: 15
Page 1 - Next Page

Scroll to top